165 related articles for article (PubMed ID: 12797852)
1. Menopause: new therapies.
Davis SR
Med J Aust; 2003 Jun; 178(12):634-7. PubMed ID: 12797852
[TBL] [Abstract][Full Text] [Related]
2. [Basic principles of hormone replacement therapy in the postmenopause].
Dören M
Ther Umsch; 2000 Oct; 57(10):628-34. PubMed ID: 11081374
[TBL] [Abstract][Full Text] [Related]
3. Pros and cons of existing treatment modalities in osteoporosis: a comparison between tibolone, SERMs and estrogen (+/-progestogen) treatments.
Kloosterboer HJ; Ederveen AG
J Steroid Biochem Mol Biol; 2002 Dec; 83(1-5):157-65. PubMed ID: 12650712
[TBL] [Abstract][Full Text] [Related]
4. Postmenopausal hormone therapy: from monkey glands to transdermal patches.
Davis SR; Dinatale I; Rivera-Woll L; Davison S
J Endocrinol; 2005 May; 185(2):207-22. PubMed ID: 15845914
[TBL] [Abstract][Full Text] [Related]
5. What happened to WHI: menopausal hormonal therapy in 2012.
Hansen KA; Eyster KM
Clin Obstet Gynecol; 2012 Sep; 55(3):706-12. PubMed ID: 22828102
[TBL] [Abstract][Full Text] [Related]
6. The effect of hormone replacement therapy and tibolone on lipoprotein (a) concentrations in postmenopausal women: A systematic review and meta-analysis.
Anagnostis P; Galanis P; Chatzistergiou V; Stevenson JC; Godsland IF; Lambrinoudaki I; Theodorou M; Goulis DG
Maturitas; 2017 May; 99():27-36. PubMed ID: 28364865
[TBL] [Abstract][Full Text] [Related]
7. [Treatments "substitute" to Hormonal Replacement Therapy of menopause].
Letonturier P
Presse Med; 2002 Sep; 31(28):1313. PubMed ID: 12374102
[No Abstract] [Full Text] [Related]
8. Selective estrogen modulators in menopause.
Gambacciani M
Minerva Ginecol; 2013 Dec; 65(6):621-30. PubMed ID: 24346250
[TBL] [Abstract][Full Text] [Related]
9. Hormone replacement therapy, selective estrogen receptor modulators, and tissue-specific compounds: cardiovascular effects and clinical implications.
Vogelvang TE; van der Mooren MJ; Mijatovic V
Treat Endocrinol; 2004; 3(2):105-15. PubMed ID: 15743106
[TBL] [Abstract][Full Text] [Related]
10. Serum lipids and apolipoproteins in Greek postmenopausal women: association with estrogen, estrogen-progestin, tibolone and raloxifene therapy.
Creatsas G; Christodoulakos G; Lambrinoudaki I; Panoulis C; Chondros C; Patramanis P
J Endocrinol Invest; 2003 Jun; 26(6):545-51. PubMed ID: 12952369
[TBL] [Abstract][Full Text] [Related]
11. Effects of a continuous-combined regimen of low-dose hormone therapy (oestradiol and norethindrone acetate) and tibolone on the quality of life in symptomatic postmenopausal women: a double-blind, randomised study.
Polisseni AF; Andrade AT; Ribeiro LC; Castro IQ; Brandão M; Polisseni F; Guerra Mde O
Maturitas; 2013 Feb; 74(2):172-8. PubMed ID: 23201326
[TBL] [Abstract][Full Text] [Related]
12. [Indications for hormone replacement therapy].
Birkhäuser MH
Ther Umsch; 2000 Oct; 57(10):635-42. PubMed ID: 11081375
[TBL] [Abstract][Full Text] [Related]
13. [Hormone replacement and selective estrogen receptor modulators (SERMS) in the prevention and treatment of postmenopausal osteoporosis].
Pfeilschifter J
Orthopade; 2001 Jul; 30(7):462-72. PubMed ID: 11515185
[TBL] [Abstract][Full Text] [Related]
14. Hormone replacement therapy: current controversies.
Davison S; Davis SR
Clin Endocrinol (Oxf); 2003 Mar; 58(3):249-61. PubMed ID: 12608928
[TBL] [Abstract][Full Text] [Related]
15. [Postmenopausal hormonal treatment: conventional hormone replacement therapy or tibolone? Effects on bone].
Reginster JY
J Gynecol Obstet Biol Reprod (Paris); 2002 Oct; 31(6):541-9. PubMed ID: 12407324
[TBL] [Abstract][Full Text] [Related]
16. Short and long term effects of tibolone in postmenopausal women.
Formoso G; Perrone E; Maltoni S; Balduzzi S; D'Amico R; Bassi C; Basevi V; Marata AM; Magrini N; Maestri E
Cochrane Database Syst Rev; 2012 Feb; (2):CD008536. PubMed ID: 22336846
[TBL] [Abstract][Full Text] [Related]
17. The role of ERT/HRT.
Samsioe G
Best Pract Res Clin Obstet Gynaecol; 2002 Jun; 16(3):371-81. PubMed ID: 12099668
[TBL] [Abstract][Full Text] [Related]
18. Comparative effects of conventional hormone replacement therapy and tibolone on climacteric symptoms and sexual dysfunction in postmenopausal women.
Ziaei S; Moghasemi M; Faghihzadeh S
Climacteric; 2010 Apr; 13(2):147-56. PubMed ID: 19731119
[TBL] [Abstract][Full Text] [Related]
19. [Alternatives to hormone replacement therapy for menopause: an epidemiological evaluation].
Ringa V
J Gynecol Obstet Biol Reprod (Paris); 2004 May; 33(3):195-209. PubMed ID: 15170434
[TBL] [Abstract][Full Text] [Related]
20. Effect of hormone replacement therapy, tibolone and raloxifene on serum lipids, apolipoprotein A1, apolipoprotein B and lipoprotein(a) in Greek postmenopausal women.
Christodoulakos GE; Lambrinoudaki IV; Panoulis CP; Papadias CA; Kouskouni EE; Creatsas GC
Gynecol Endocrinol; 2004 May; 18(5):244-57. PubMed ID: 15346660
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
